Literature DB >> 21824262

Regulation of glucagon secretion by glucose: paracrine, intrinsic or both?

J N Walker1, R Ramracheya, Q Zhang, P R V Johnson, M Braun, P Rorsman.   

Abstract

Glucagon secretion is regulated by glucose but the mechanisms involved remain hotly debated. Both intrinsic (within the α-cell itself) and paracrine (mediated by factors released β- and/or δ-cells) have been postulated. Glucagon secretion is maximally suppressed by glucose concentrations that do not affect insulin and somatostatin secretion, a finding that highlights the significance of intrinsic regulation of glucagon secretion. Experiments on islets from mice lacking functional ATP-sensitive potassium channels (K(ATP)-channels) indicate that these channels are critical to the α-cell's capacity to sense changes in extracellular glucose. Here, we review recent data on the intrinsic and paracrine regulation of glucagon secretion in human pancreatic islets. We propose that glucose-induced closure of the K(ATP)-channels, via membrane depolarization, culminates in reduced electrical activity and glucagon secretion by voltage-dependent inactivation of the ion channels involved in action potential firing. We further demonstrate that glucagon secretion measured in islets isolated from donors with type-2 diabetes is reduced at low glucose and that glucose stimulates rather than inhibits secretion in these islets. We finally discuss the relative significance of paracrine and intrinsic regulation in the fed and fasted states and propose a unifying model for the regulation of glucagon secretion that incorporates both modes of control.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21824262     DOI: 10.1111/j.1463-1326.2011.01450.x

Source DB:  PubMed          Journal:  Diabetes Obes Metab        ISSN: 1462-8902            Impact factor:   6.577


  82 in total

1.  Glycemic control in diabetes is restored by therapeutic manipulation of cytokines that regulate beta cell stress.

Authors:  Sumaira Z Hasnain; Danielle J Borg; Brooke E Harcourt; Hui Tong; Yonghua H Sheng; Choa Ping Ng; Indrajit Das; Ran Wang; Alice C-H Chen; Thomas Loudovaris; Thomas W Kay; Helen E Thomas; Jonathan P Whitehead; Josephine M Forbes; Johannes B Prins; Michael A McGuckin
Journal:  Nat Med       Date:  2014-11-02       Impact factor: 53.440

Review 2.  Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes.

Authors:  Philip E Cryer
Journal:  Endocrinology       Date:  2011-12-13       Impact factor: 4.736

3.  Paracrine regulation of glucagon secretion: the β/α/δ model.

Authors:  Margaret Watts; Joon Ha; Ofer Kimchi; Arthur Sherman
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-02-02       Impact factor: 4.310

4.  Dynamic monitoring of glucagon secretion from living cells on a microfluidic chip.

Authors:  Jonathan G Shackman; Kendra R Reid; Colleen E Dugan; Robert T Kennedy
Journal:  Anal Bioanal Chem       Date:  2012-03       Impact factor: 4.142

5.  High-fat diet consumption during pregnancy and the early post-natal period leads to decreased α cell plasticity in the nonhuman primate.

Authors:  Sarah M Comstock; Lynley D Pound; Jacalyn M Bishop; Diana L Takahashi; Ashley M Kostrba; M Susan Smith; Kevin L Grove
Journal:  Mol Metab       Date:  2012-11-14       Impact factor: 7.422

Review 6.  Improving the physiological realism of experimental models.

Authors:  Kalyan C Vinnakota; Chae Y Cha; Patrik Rorsman; Robert S Balaban; Andre La Gerche; Richard Wade-Martins; Daniel A Beard; Jeroen A L Jeneson
Journal:  Interface Focus       Date:  2016-04-06       Impact factor: 3.906

7.  Synchronized stimulation and continuous insulin sensing in a microfluidic human Islet on a Chip designed for scalable manufacturing.

Authors:  Aaron L Glieberman; Benjamin D Pope; John F Zimmerman; Qihan Liu; John P Ferrier; Jennifer H R Kenty; Adrian M Schrell; Nikita Mukhitov; Kevin L Shores; Adrian Buganza Tepole; Douglas A Melton; Michael G Roper; Kevin Kit Parker
Journal:  Lab Chip       Date:  2019-09-10       Impact factor: 6.799

Review 8.  Ghrelin, the proglucagon-derived peptides and peptide YY in nutrient homeostasis.

Authors:  Charlotte X Dong; Patricia L Brubaker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-10-02       Impact factor: 46.802

9.  Assessment of glycemic response to an oral glucokinase activator in a proof of concept study: application of a semi-mechanistic, integrated glucose-insulin-glucagon model.

Authors:  Karen B Schneck; Xin Zhang; Robert Bauer; Mats O Karlsson; Vikram P Sinha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-22       Impact factor: 2.745

10.  Dose selection using a semi-mechanistic integrated glucose-insulin-glucagon model: designing phase 2 trials for a novel oral glucokinase activator.

Authors:  Xin Zhang; Karen Schneck; Juliana Bue-Valleskey; Kwee Poo Yeo; Michael Heathman; Vikram Sinha
Journal:  J Pharmacokinet Pharmacodyn       Date:  2012-12-22       Impact factor: 2.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.